Estrogen Phenolic NDC 44911-0199

NDC codes

FDA NDC Directory

Product NDC (as listed)44911-0199Labeler and product segments. Claims need a package NDC.

Product NDC at billing width44911-0199Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
44911-0199-1	44911019901	30 mL in 1 BOTTLE, DROPPER (44911-0199-1)Marketed from Jul 9, 2015

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Estrogen Phenolic
Generic name (nonproprietary): estradiol,
Active ingredients: Estradiol — 6 [hp_X]/mL
Dosage form: Liquid
Route: Oral
Labeler: Energique, Inc.
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Jul 9, 2015
Listing expires: Dec 31, 2026
Other FDA classes: Estradiol Congeners (Chemical structure)Estrogen Receptor Agonists (Mechanism)
Identifiers: Product ID 44911-0199_bc59e68e-4c34-4e8c-8fd3-50b11ef6aba4SPL ID bc59e68e-4c34-4e8c-8fd3-50b11ef6aba4SPL set ID 716cd86c-af47-45a6-b710-fed421e78fb5UNII 4TI98Z838EUPC 0363113600193
Pharmacologic class: Estrogen

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N444911019901 followed by a unit qualifier and the quantity

Package 44911-0199-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 24, 2024.

Indications (excerpt from the label)

INDICATIONS: May temporarily relieve symptoms associated with reactions to estrogen, such as breast tenderness and menopausal symptoms.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)